Merck & Co., Inc. (LON:MRK)

VMware Statistics

Total Valuation

Merck & Co. has a market cap or net worth of GBP 149.65 billion. The enterprise value is 169.66 billion.

Market Cap	149.65B
Enterprise Value	169.66B

Important Dates

The last earnings date was Tuesday, July 29, 2025.

Earnings Date	Jul 29, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-0.77%
Shares Change (QoQ)	-0.71%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	2.49B

Valuation Ratios

The trailing PE ratio is 12.50 and the forward PE ratio is 8.73.

PE Ratio	12.50
Forward PE	8.73
PS Ratio	3.22
PB Ratio	4.18
P/TBV Ratio	16.79
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.88, with an EV/FCF ratio of 15.79.

EV / Earnings	14.17
EV / Sales	3.58
EV / EBITDA	7.88
EV / EBIT	9.46
EV / FCF	15.79

Financial Position

The company has a current ratio of 1.42, with a Debt / Equity ratio of 0.72.

Current Ratio	1.42
Quick Ratio	0.82
Debt / Equity	0.72
Debt / EBITDA	1.23
Debt / FCF	2.40
Interest Coverage	18.86

Financial Efficiency

Return on equity (ROE) is 35.42% and return on invested capital (ROIC) is 18.13%.

Return on Equity (ROE)	35.42%
Return on Assets (ROA)	13.07%
Return on Invested Capital (ROIC)	18.13%
Return on Capital Employed (ROCE)	26.30%
Revenue Per Employee	627,477
Profits Per Employee	161,821
Employee Count	75,000
Asset Turnover	0.55
Inventory Turnover	2.20

Taxes

In the past 12 months, Merck & Co. has paid 2.00 billion in taxes.

Income Tax	2.00B
Effective Tax Rate	14.32%

Stock Price Statistics

The stock price has decreased by -6.92% in the last 52 weeks. The beta is 0.69, so Merck & Co.'s price volatility has been lower than the market average.

Beta (5Y)	0.69
52-Week Price Change	-6.92%
50-Day Moving Average	60.27
200-Day Moving Average	56.61
Relative Strength Index (RSI)	47.72
Average Volume (20 Days)	21,584

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.89

Income Statement

In the last 12 months, Merck & Co. had revenue of GBP 46.43 billion and earned 11.97 billion in profits. Earnings per share was 4.73.

Revenue	46.43B
Gross Profit	35.94B
Operating Income	17.56B
Pretax Income	13.99B
Net Income	11.97B
EBITDA	20.83B
EBIT	17.56B
Earnings Per Share (EPS)	4.73

Balance Sheet

The company has 6.29 billion in cash and 25.84 billion in debt, giving a net cash position of -19.55 billion.

Cash & Cash Equivalents	6.29B
Total Debt	25.84B
Net Cash	-19.55B
Net Cash Per Share	n/a
Equity (Book Value)	35.81B
Book Value Per Share	14.29
Working Capital	8.05B

Cash Flow

In the last 12 months, operating cash flow was 13.53 billion and capital expenditures -2.78 billion, giving a free cash flow of 10.75 billion.

Operating Cash Flow	13.53B
Capital Expenditures	-2.78B
Free Cash Flow	10.75B
FCF Per Share	n/a

Margins

Gross margin is 77.41%, with operating and profit margins of 37.82% and 25.79%.

Gross Margin	77.41%
Operating Margin	37.82%
Pretax Margin	30.12%
Profit Margin	25.79%
EBITDA Margin	44.86%
EBIT Margin	37.82%
FCF Margin	23.14%

Dividends & Yields

Merck & Co. does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	48.95%
Buyback Yield	0.77%
Shareholder Yield	n/a
Earnings Yield	8.00%
FCF Yield	7.18%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Merck & Co. has an Altman Z-Score of 4.34 and a Piotroski F-Score of 5.

Altman Z-Score	4.34
Piotroski F-Score	5